US-based pharmaceutical company Lilly will sell its assets in Puerto Rico
La farmacéutica estadounidense Lilly venderá sus activos en Puerto Rico
Intel ID : 219747
| Synopsis |
|
US-based pharmaceutical company Lilly announced the sale of its production plant in Guayama, Puerto Rico. The company has not found a buyer yet, but confirmed it wants to close this process before the end of 2015.
(content in spanish)
La farmacéutica estadounidense Lilly ha anunciado que ha puesto a la venta su planta de producción en Guayama, municipio del sur de Puerto Rico. La compañía aún no ha encontrado comprador para los activos, pero sí ha confirmado que pretende que el proceso esté cerrado antes de finales de 2015. |
|
||||
Relevant Documents
| Press Release | 16 Oct 2014 | Lilly_Press_Release_2014.pdf | ES |
|
| Intel ID | 219747 | |
| Value | ND | |
| Native Currency |
US Dollar (USD)
Exchange Rate:  |
|
| Date |
|
|
| Country | |
|
| Region | ||
| Continent | |
|
| Geography |  |
|
| Subsector (Old TTR Sectors) |
|
|
| Type |
|
|
| Intel Grade |
|
|
| Source |
|
|
| Tags | |
Target
| Name |
|
||
| Subsector (Old TTR Sectors) |
|
||
| Country |
|
||
| Description |
|
Seller
| Name |
|
||
| Subsector (Old TTR Sectors) |
|
||
| Primary Sector (TTRSC) |
30.01.03 Pharmaceutical R&D, Manufacturing & Distribution 30 Healthcare / 30.01 Biotechnology & Pharmaceuticals |
||
| Country |
|
||
| Website |
|
||
| Description |
|
Legend:
Verified: Confirmed as a party to an active or possible transaction.
Potential: Unconfirmed as a party to an active or possible transaction.
Retained: Confirmed as “Retained” with a general or specific mandate.
Prospect: Advisory “Prospect” in discussions with or pitching services to possible client.
Transactional data is continuously updated by the research team and therefore is subject to change.